…
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Astrotech Corporation (NASDAQ: ASTC) is a small public company that focuses on acquiring and commercializing advanced technologies originating from government research, including capabilities related to detection and space-support applications. Long-term growth may benefit from successful product commercialization, licensing revenue and wider adoption of niche technical solutions, and the company could appeal to investors seeking exposure to early-stage technology commercialization with upside if market acceptance grows.
The most important investment risks are limited revenue visibility and operating scale, execution risk in bringing technologies to market, reliance on a small set of products or contracts, and potential need for additional financing or equity dilution.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | -13.85M | -11.66M | -9.64M | -8.33M | -7.60M |
| Net income | -13.85M | -11.67M | -9.64M | -7.56M | -7.61M |
| Selling general administrative | 7.07M | 1.36M | 5.78M | 6.01M | 4.74M |
| Selling and marketing expenses | - | 5.88M | - | - | - |
| Gross profit | 0.47M | 0.75M | 0.31M | 0.19M | 0.04M |
| Reconciled depreciation | 1.16M | 0.87M | 0.49M | 0.24M | 0.20M |
| Ebit | -13.85M | -13.28M | -11.55M | -8.83M | -7.40M |
| Ebitda | -12.69M | -12.41M | -11.06M | -8.60M | -7.43M |
| Depreciation and amortization | 1.16M | 0.87M | 0.49M | 0.24M | -0.03M |
| Operating income | -14.73M | -13.28M | -11.06M | -8.60M | -7.40M |
| Other operating expenses | 15.78M | 14.94M | 11.81M | 9.46M | 7.73M |
| Interest expense | - | - | - | 0.27M | -0.23M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | - | - | - | 0.27M | -0.23M |
| Income tax expense | 0.00M | 0.00M | -0.49M | -0.77M | 0.00M |
| Total revenue | 1.05M | 1.66M | 0.75M | 0.87M | 0.33M |
| Total operating expenses | 15.21M | 14.03M | 11.37M | 8.79M | 7.43M |
| Cost of revenue | 0.57M | 0.91M | 0.44M | 0.68M | 0.30M |
| Total other income expense net | 0.89M | 1.62M | 1.42M | 0.27M | -0.21M |
| Net income from continuing ops | -13.85M | -11.67M | -9.64M | -8.33M | -7.60M |
| Net income applicable to common shares | - | - | -9.64M | -8.33M | -7.60M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 26.99M | 37.64M | 47.67M | 56.22M | 65.63M |
| Intangible assets | 0.05M | - | - | - | - |
| Other current assets | 0.35M | 0.26M | 0.36M | 0.75M | 0.32M |
| Total liab | 4.89M | 2.83M | 2.96M | 2.98M | 4.43M |
| Total stockholder equity | 22.10M | 34.81M | 44.72M | 53.24M | 61.21M |
| Other current liab | 0.98M | 1.93M | 1.80M | 1.78M | 1.23M |
| Common stock | 190.64M | 190.64M | 190.64M | 190.64M | 190.64M |
| Capital stock | 190.64M | 190.64M | 190.64M | 190.64M | 190.64M |
| Retained earnings | -250.87M | -237.02M | -225.35M | -215.71M | -207.38M |
| Other assets | - | - | 0.03M | 0.01M | 0.01M |
| Cash | 3.10M | 10.44M | 14.21M | 26.45M | 35.94M |
| Total current liabilities | 2.45M | 2.53M | 2.67M | 2.68M | 4.21M |
| Current deferred revenue | - | 0.34M | - | - | - |
| Net debt | -0.42M | -10.14M | -13.60M | -25.42M | -33.14M |
| Short term debt | 0.41M | 0.23M | 0.32M | 0.73M | 2.58M |
| Short long term debt | - | - | - | 0.50M | 2.50M |
| Short long term debt total | 2.68M | 0.30M | 0.61M | 1.04M | 2.80M |
| Other stockholder equity | 83.19M | 82.36M | 80.88M | 79.50M | 77.97M |
| Property plant equipment | - | - | 2.93M | 1.26M | 0.51M |
| Total current assets | 21.98M | 34.73M | 44.71M | 54.95M | 65.11M |
| Net tangible assets | - | - | 44.72M | 53.24M | 61.21M |
| Short term investments | 15.11M | 21.47M | 27.92M | 26.17M | 27.35M |
| Net receivables | 0.48M | 0.08M | 0.23M | 0.06M | 0.01M |
| Inventory | 2.93M | 2.47M | 2.00M | 1.52M | 1.50M |
| Accounts payable | 1.07M | 0.37M | 0.55M | 0.17M | 0.40M |
| Accumulated other comprehensive income | -0.86M | -1.18M | -1.45M | -1.20M | -0.02M |
| Common stock total equity | - | - | - | - | 190.64M |
| Non currrent assets other | 0.35M | 0.03M | 0.03M | 0.01M | 0.01M |
| Non current assets total | 5.01M | 2.91M | 2.96M | 1.27M | 0.52M |
| Capital lease obligations | 2.68M | 0.30M | 0.61M | 0.54M | 0.30M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | 5.79M | 6.14M | -3.84M | -0.60M | -27.37M |
| Change to liabilities | - | - | 0.38M | -0.23M | 0.16M |
| Total cashflows from investing activities | 5.79M | 6.14M | -3.84M | -0.60M | -27.59M |
| Net borrowings | -0.18M | -0.18M | -0.66M | -2.10M | -0.01M |
| Total cash from financing activities | -0.18M | -0.18M | -0.78M | -2.10M | 67.58M |
| Change to operating activities | - | - | 0.26M | 0.07M | -0.12M |
| Net income | -13.85M | -11.67M | -9.64M | -8.33M | -7.60M |
| Change in cash | -7.34M | -3.77M | -12.24M | -9.48M | 32.59M |
| Begin period cash flow | 10.44M | 14.21M | 26.45M | 35.94M | 3.35M |
| End period cash flow | 3.10M | 10.44M | 14.21M | 26.45M | 35.94M |
| Total cash from operating activities | -12.95M | -9.72M | -7.62M | -6.79M | -7.41M |
| Issuance of capital stock | - | - | - | 0.00M | 67.58M |
| Depreciation | 1.16M | 0.87M | 0.49M | 0.24M | 0.20M |
| Other cashflows from investing activities | -0.05M | - | - | - | - |
| Change to inventory | -0.46M | -0.48M | -0.48M | -0.02M | -0.82M |
| Change to account receivables | -0.41M | 0.15M | -0.17M | -0.05M | 0.10M |
| Sale purchase of stock | - | 0.00M | -0.12M | - | - |
| Other cashflows from financing activities | -0.18M | 6.14M | -3.84M | -0.60M | -27.59M |
| Change to netincome | - | - | 1.54M | 1.53M | 0.26M |
| Capital expenditures | 0.83M | 0.58M | 1.84M | 0.60M | 0.21M |
| Change in working capital | -1.39M | -0.42M | -0.01M | -0.23M | -0.27M |
| Stock based compensation | 0.83M | 1.48M | 1.50M | 1.53M | 0.63M |
| Other non cash items | 0.30M | 0.01M | 0.01M | - | -0.37M |
| Free cash flow | -13.79M | -10.30M | -9.47M | -7.39M | -7.62M |
Sector: Technology Industry: Scientific & Technical Instruments
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ASTC Astrotech Corp |
0.09 2.13% |
4.32 | - | 10.21 | 5.24 | 0.38 | 0.06 | 16.55 |
| KYCCF Keyence |
28.50 6.47% |
469.00 | 41.66 | 38.76 | 0.11 | 5.69 | 0.10 | 0.19 |
| COHR Coherent Corp |
29.18 15.13% |
221.99 | 333.78 | 46.73 | 10.24 | 7.63 | 10.78 | 62.92 |
| GRMN Garmin Ltd |
5.66 1.98% |
291.23 | 28.91 | 24.45 | 7.01 | 5.99 | 6.72 | 22.32 |
| KEYS Keysight Technologies Inc |
14.43 5.30% |
286.56 | 42.58 | 20.00 | 8.11 | 8.16 | 8.17 | 28.06 |
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas Boone Pickens III | Chairman & CEO | 1957 |
| Mr. Jaime Hinojosa | CFO, Treasurer & Sec. | 1982 |
| Mr. Joe Levinthal | Chief Science Officer of AgLAB Inc. | NA |
| Mr. Thomas Boone Pickens III | CEO, CTO & Chairman | 1957 |
| Mr. Jaime Hinojosa | CFO, Treasurer & Secretary | 1982 |
| Mr. Scott Campbell Bartley CPA | Interim Chief Financial Officer | 1969 |
| Mr. Nihanth Badugu | Chief Operating Officer | 1988 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.